Roger D. Dansey - 13 May 2024 Form 4 Insider Report for INOVIO PHARMACEUTICALS, INC. (INO)

Role
Director
Signature
/s/ Roger Dansey
Issuer symbol
INO
Transactions as of
13 May 2024
Net transactions value
$0
Form type
4
Filing time
13 May 2024, 17:56:11 UTC
Previous filing
15 Dec 2023
Next filing
16 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INO Common Stock Options Exercise +1,000 +28% 4,583 13 May 2024 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INO Restricted Stock Unit Options Exercise $0 -1,000 -100% $0.000000* 0 13 May 2024 Common Stock 1,000 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 3,000 restricted stock units was as follows: 1,000 shares vested on May 13, 2022; 1,000 shares vested on May 13, 2023; and 1,000 shares vested on May 13, 2024. Vested restricted stock units could be settled in shares of common stock, cash or a combination of both.
F2 Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024.